Investor's Business Daily on MSN
Why Arcus Biosciences just reversed its 287% eight-month winning streak
Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen ...
Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have ...
A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...
Confused about protein recommendations? We asked protein experts on what exactly is the answer. Plus, everything else you ...
IND filing and initiation of Phase 2 clinical trials on track for 1H 2026SAN DIEGO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cullgen ...
HIGHLIGHTSAn additional confirmed partial response has been recorded in the ongoing ACCENT trialThis brings the confirmed Objective Response Rate ...
Patients whose cancers were hormone receptor (HR) negative – that is, their tumor cells did not have proteins that bind to ...
Researchers have found a way to control protein levels inside different tissues of a whole, living animal for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback